Adriano Care SOCIMI SAU (YADR) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Adriano Care SOCIMI SAU stock €9.53, price €9.85, that is 3.2% below the price, quality 67 out of 100. Rating: fairly valued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range €8.68 – €11.70 · fair‑value band €6.22 – €13.65 · the €9.85 price screens above the €9.53 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow Adriano Care SOCIMI SAU in your weekly email
Every Wednesday you see whether Adriano Care SOCIMI SAU is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Adriano Care SOCIMI, S.A. invests in real estate assets related with the elderly. It focuses its investments in senior housing, residential adapted to elderly needs, and other care centres for the elderly. The company is based in Madrid, Spain.
Stock analysis
Adriano Care SOCIMI SAU (YADR) currently trades at €9.85, while our model-based Fair Value estimate is €9.53, so the stock looks roughly fairly valued today (gap 3.4%).
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of €11.38 per share, and 9 of the 16 models we run sit above the €9.85 price.
Bear case: the Asset-Based group reads lowest at €7.30, and 7 of the 16 models stay below the price. Data coverage for this calculation is high.
Scenario range: €6.22 (bear) to €13.65 (bull), the price of €9.85 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 67/100 (solid quality), in the Real Estate sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Adriano Care SOCIMI SAU reported revenue of €17.9M in FY2025 versus €13.3M in FY2021, a compound +7.7%/yr. Reported net income was €12.8M in FY2025, compounding +11.5%/yr from FY2021.
Key figures
Market cap €118M Micro · P/E ratio 9.2 · P/S ratio 6.58 · EPS (TTM) €1.07 · Dividend yield 11.1% · Net margin 71.6% · Return on equity 9.5% · Return on assets (EBIT) 3.6% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 69 out of 100 (low confidence).
What moves the price
The share trades about 16% below its 52-week high and 13% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Real Estate peers we cover trades at −19% fair-value upside, at −3%, YADR screens cheaper than that median.
Fair Value models
Bear€6.22Fair Value €9.53Bull€13.65
Price €9.85 · Downside -3.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (€0.9176 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.72/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+3.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.8%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+30.4%
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
≈ +12.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year+1.8%
Dividend (yield on the price)11.1%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−14% → 51%
⚠ Rate on operating basis: 2025 sits 70% above its own trend.
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+32.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about +29.6% a year for the price.
Compare Adriano Care SOCIMI SAU with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.REIT - Healthcare Facilities · 25 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Adriano Care SOCIMI SAU Fair Value". https://www.fairvalue-calculator.com/stock/YADR
Frequently asked questions
Is Adriano Care SOCIMI SAU (YADR) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of €9.53 versus a price of €9.85, about 3% lower (fairly valued).
What is the fair value of YADR?
Our model-based fair value for Adriano Care SOCIMI SAU is €9.53 (as of Nov 8, 2026), built from audited fundamentals. The current price: €9.85.
What is the quality score of YADR?
Adriano Care SOCIMI SAU has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Adriano Care SOCIMI SAU (YADR)?
Our model-based price target is the fair value of €9.53 (as of Nov 8, 2026) from 16 valuation models. Cautious scenario €6.22, optimistic scenario €13.65. It is a calculation from audited fundamentals, not an analyst target.
What is the Adriano Care SOCIMI SAU stock forecast for 2026?
Our models put fair value at €9.53, about 3% lower versus a price of €9.85 (fairly valued). Cautious scenario €6.22, optimistic scenario €13.65. The calculation is refreshed regularly with new filings.
What is the revenue of Adriano Care SOCIMI SAU (YADR)?
Adriano Care SOCIMI SAU reported trailing-twelve-month revenue of about €17.9M (latest available figure, as of Nov 8, 2026).
Does Adriano Care SOCIMI SAU pay a dividend?
Adriano Care SOCIMI SAU currently shows a dividend yield of 11.06% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of Adriano Care SOCIMI SAU (YADR)?
Adriano Care SOCIMI SAU has a dividend yield of 11.1%.
What growth is priced into Adriano Care SOCIMI SAU (YADR)?
For today's price to be fair in a discounted-cash-flow model, Adriano Care SOCIMI SAU would have to grow free cash flow by +32.4 % per year for five years (discount rate 14.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +7.8 % per year. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of YADR use?
Our models discount Adriano Care SOCIMI SAU at 14.1 %: a base by market capitalisation (micro), country premium for Spain. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Adriano Care SOCIMI SAU that is +32.4 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (14.1 %) and the same formula as our fair value.
How much growth has Adriano Care SOCIMI SAU (YADR) delivered so far?
Over the past 5 years revenue at Adriano Care SOCIMI SAU grew +7.8 % a year. The price currently implies free-cash-flow growth of +32.4 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Adriano Care SOCIMI SAU (YADR) growing?
The median revenue growth in the sector is +2.7 % a year. That is the yardstick for the growth priced into Adriano Care SOCIMI SAU (+32.4 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Adriano Care SOCIMI SAU (YADR)?
The free-cash-flow yield on the price is 4.78 %: that much free cash flow Adriano Care SOCIMI SAU produces per unit of market value. When it exceeds the discount rate of our models (14.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Adriano Care SOCIMI SAU (YADR)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Adriano Care SOCIMI SAU it is €9.53 per share (as of Nov 8, 2026), against a price of €9.85. It is the blended result of 16 valuation models in 6 families (DCF Models, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit).
Is Adriano Care SOCIMI SAU stock overvalued or undervalued in 2026?
As of Nov 8, 2026, YADR trades above its calculated fair value: price €9.85, fair value €9.53, a gap of about −3% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of YADR?
No. The price is what the market pays today (€9.85); the fair value is what the company's own numbers justify (€9.53). For Adriano Care SOCIMI SAU the two are €0.3200 per share apart. That gap is exactly why we show both numbers side by side.
How much is Adriano Care SOCIMI SAU worth?
The market values Adriano Care SOCIMI SAU at about €118M (market capitalisation, as of Nov 8, 2026). Per share that is €9.85; our models calculate a fair value of €9.53 per share.
What do the bullish and bearish scenarios say about YADR?
Our models span a range for Adriano Care SOCIMI SAU: cautious scenario €6.22, base €9.53, optimistic €13.65 per share (as of Nov 8, 2026, price €9.85). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of YADR?
Adriano Care SOCIMI SAU trades at a price-to-earnings ratio of 9.2 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €9.53 is built from several models across several years. Other multiples: P/B 0.9, P/S 6.6, EV/EBITDA 13.6.
How solid is the balance sheet of Adriano Care SOCIMI SAU (YADR)?
Balance-sheet figures for Adriano Care SOCIMI SAU (as of Nov 8, 2026): return on equity 9.5%, debt of 0.10 per unit of equity. They feed the Quality Score of 67/100, which measures business quality independently of the share price.
How far is YADR from its 52-week high?
Adriano Care SOCIMI SAU trades at €9.85, about 16% below its 52-week high of €11.70 and 13% above the low of €8.70 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of €9.53 is for.
Which stocks are comparable to Adriano Care SOCIMI SAU?
From the same area (Real Estate) we also value Welltower Inc, Ventas, Inc, Omega Healthcare Investors, Inc, Healthpeak Properties, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Adriano Care SOCIMI SAU stock attractive at the current price?
The data as of Nov 8, 2026: price €9.85, calculated fair value €9.53 (−3%), Quality Score 67/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of YADR calculated?
We run Adriano Care SOCIMI SAU through 16 models from 6 families: DCF Models, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit. Every model gets the same audited fundamentals; the fair value of €9.53 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Adriano Care SOCIMI SAU itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Adriano Care SOCIMI SAU (YADR)?
The closing price on Nov 6, 2026 was €9.85. Our model-based fair value is €9.53, about 3% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Adriano Care SOCIMI SAU right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (€6.22 to €13.65) leaves room in how you read the outcome. As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Key figures of Adriano Care SOCIMI SAU
How large is the market capitalisation of Adriano Care SOCIMI SAU (YADR)?
The market capitalisation of Adriano Care SOCIMI SAU is €118M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Adriano Care SOCIMI SAU (YADR)?
The price-to-sales ratio of Adriano Care SOCIMI SAU is 6.58 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Adriano Care SOCIMI SAU (YADR)?
Earnings per share at Adriano Care SOCIMI SAU are €1.07 (price ÷ EPS = P/E 9.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Adriano Care SOCIMI SAU (YADR)?
The dividend yield of Adriano Care SOCIMI SAU is 11.1% (payout 102%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Adriano Care SOCIMI SAU (YADR)?
The net margin of Adriano Care SOCIMI SAU is 71.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Adriano Care SOCIMI SAU (YADR)?
The return on equity (ROE) of Adriano Care SOCIMI SAU is 9.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Adriano Care SOCIMI SAU (YADR)?
On an EBIT basis the return on assets of Adriano Care SOCIMI SAU is 3.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Adriano Care SOCIMI SAU (YADR)?
The operating margin of Adriano Care SOCIMI SAU is 46.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Adriano Care SOCIMI SAU (YADR)?
Revenue at Adriano Care SOCIMI SAU is growing −0.1% versus a year earlier (3y avg +18.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does Adriano Care SOCIMI SAU (YADR) carry?
The net debt of Adriano Care SOCIMI SAU is €102M (fiscal year 2025, ≈ 18.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Adriano Care SOCIMI SAU in the live analysis
One click puts Adriano Care SOCIMI SAU on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 8, 2026